Overview

Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea

Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
0
Participant gender:
All
Summary
This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persists after adenotonsillectomy, the surgery that removes the tonsils and adenoids.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Erin Kirkham
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Dexmedetomidine
Propofol
Criteria
Inclusion Criteria:

1. Diagnosed with Obstructive sleep apnea (OSA) by the following criteria: Obstructive
Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5, confirmed on nocturnal,
laboratory-based polysomnography within the previous 6 months scored using American
Academy of Sleep Medicine pediatric criteria in an accredited sleep lab.

2. Considered to be a surgical candidate for adenotonsillectomy to treat OSA by an
board-certified or board-eligible otolaryngologist.

3. Clinical determination by the child's otolaryngologist surgeon that the child would
benefit from sleep endoscopy prior to adenotonsillectomy due to one or more reported
risk factors for residual sleep apnea after surgery, which may include:

1. Obese (>95th percentile of body mass index for age)

2. Severe preoperative OSA (AHI ≥10 events/hour)

3. Discordance between awake physical exam (eg. small tonsils) and sleep apnea
symptoms or severity;

4. African American race

5. Age ≥7 years old

4. Male or Female ages 3.00 - 11.99 years

5. Parent/guardian ability to understand and willingness to sign a written informed
consent..

6. Parent/guardian must understand/read/speak English or Spanish and be able and willing
to complete questionnaires.

Exclusion Criteria:

1. Previous adenotonsillectomy or other upper airway surgery (including tracheostomy)
with the exception of isolated adenoidectomy if it occurred >18 months prior to
recruitment.

2. Major medical diagnosis that may be exacerbated by the study treatment, pose undue
risk to the patient, or that may impact interpretation of study results

3. History of allergic reaction to or contraindication to receiving propofol,
dexmedetomidine, ketamine or sevoflurane

4. Allergy to eggs, egg products, soybeans or soybean products.

5. Contraindication to receiving general anesthesia